Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 13Rectal Neoplasms 4Neoplasm Metastasis 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Advanced Solid Tumors 2Stomach Neoplasms 1Solid Tumor Cancer 1Sarcoma, Ewing 1Sarcoma 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Microsatellite-stable Colorectal Cancer 1Metastatic Gastric Adenocarcinoma 1Lung Neoplasms 1HER2 IHC3+ Advanced Colorectal Cancer 1Endometrial Neoplasms 1Desmoid Tumors 1Craniopharyngioma 1Colorectal Cancer Metastatic 1Breast Neoplasms 1Anal Cancer Metastatic 1Advanced Microsatellite Stable Colorectal Cancer 1Adenomatous Polyposis Coli 1

Interventions

trifluridine tipiracil drug combination 1tipiracil 1Trifluridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor Cancer × trifluridine tipiracil drug combination × 90 days × Clear all
NCT07492173 2026-03-25

Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

Shandong New Time Pharmaceutical Co., LTD

Phase NA Completed
76 enrolled
Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡